1. Prostatic artery embolization versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomized, multicentre, open-label, phase 3, superiority trial;Sapoval;Lancet Reg Health Eur,2023
2. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia;McConnell;N Engl J Med,2003
3. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study;Roehrborn;Eur Urol,2010
4. Radiation exposure during prostatic artery embolisation: a systematic review and calculation of associated risks;Zumstein;Eur Urol Focus,2021
5. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023;Sandhu;J Urol,2023